Biomarkers for Pain in Spinal Cord Injury Patients
Key facts
- Who runs it
- The University of Texas Health Science Center, Houston
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 120 people enrolled
- Started
- Jun 2009
- Ended
- Jun 2026
- Type of study
- Observational, 3 groups
- Treatments tested
- blood samples
- Record updated
- 16 June 2026
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 18 criteriaShow less
Other criteria
- Chronic Patients; Inclusion:
- Two or more years post traumatic SCI with deficit; Exclusion:
- < 18 years of age
- Evidence of brain injury on computed tomography (CT) (SCI patients need to be able to comply with completing the pain survey)
- Other medical condition that accounts for chronic pain (i.e. diabetic neuropathy, renal insufficiency, multiple sclerosis, HIV associated neuropathy, alcohol-related neuropathy)
- Temperature > 100.5°C
- History of infection within the last 30 days (i.e. UTI, URI, pressure sore)
- History of Pulmonary Embolus (PE) or deep vein thrombosis (DVT)
- Inability to obtain informed consent
- Psychiatric problems (patients need to be able to complete the pain survey)
- Diagnosis or treatment of cancer in the last 5 years
- Longitudinal, Prospective Cohort Patients:; Inclusion:
- Initial traumatic SCI with deficit; Exclusion:; Same as listed above C. Healthy Volunteers Healthy volunteers include gender, age and race matched volunteers able to provide informed consent who have,
- No significant medical history (pain free)
- No recent infections
- Take no medications
- Fever free
- Greater than 18 years old
Where in United States
- Memorial Hermann HospitalHouston, United States
About the trial
What the trial wants to find out
The investigators propose to compare plasma protein profiles for SCI patients with/without chronic neuropathic pain in order identify biomarker(s) that are associated with this medical condition. Secondly, the investigators propose to identify a temporal relationship to initial SCI at which these biomarkers manifest.
Read full original descriptionShow less
Our working hypothesis is that sustained alterations in specific inflammatory molecules are associated with chronic neuropathic pain following SCI, and that their plasma levels can serve as biomarkers to identify patients at risk for the development of neuropathic pain.
Additionally the investigators are collecting skin tissue biopsy samples from patients following acute and chronic spinal cord injury to create vector-free human iPS cells from fibroblasts by direct delivery of reprogramming proteins.
The 3 groups in the trial
- Acute-Longitudinal SCI
Treatment: blood samples
- Chronic SCI
Treatment: blood samples
- Healthy volunteers
Treatment: blood samples
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Biomarkers for Pain in Spinal Cord Injury (SCI) Patients
- Record updated
- 16 June 2026